BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 29548617)

  • 1. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series.
    Abdelrahim M; Al-Rawi H; Esmail A; Xu J; Umoru G; Ibnshamsah F; Abudayyeh A; Victor D; Saharia A; McMillan R; Al Najjar E; Bugazia D; Al-Rawi M; Ghobrial RM
    Curr Oncol; 2022 May; 29(5):3585-3594. PubMed ID: 35621680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
    Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A
    Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
    Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
    J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience.
    Abdelrahim M; Esmail A; Xu J; Umoru G; Al-Rawi H; Saharia A; Abudayyeh A; Victor D; McMillan R; Kodali S; Ghobrial RM
    Front Oncol; 2022; 12():908687. PubMed ID: 35719974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
    Maithel SK; Keilson JM; Cao HST; Rupji M; Mahipal A; Lin BS; Javle MM; Cleary SP; Akce M; Switchenko JM; Rocha FG
    Ann Surg Oncol; 2023 Oct; 30(11):6558-6566. PubMed ID: 37368098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
    Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
    Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.
    Duignan S; Maguire D; Ravichand CS; Geoghegan J; Hoti E; Fennelly D; Armstrong J; Rock K; Mohan H; Traynor O
    HPB (Oxford); 2014 Jan; 16(1):91-8. PubMed ID: 23600750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Strategy of Liver Transplantation for Locally Advanced Unresectable Perihilar Cholangiocarcinoma Using Living Grafts With Simultaneous Resection of Recipients' Hepatic Artery and Portal Vein Without Neoadjuvant Radiation: A Case Report.
    Miyagi S; Fujio A; Nakagawa K; Tokodai K; Kashiwadate T; Miyazawa K; Sasaki K; Matsumura M; Nishimaki H; Hibi T; Kamei T; Unno M
    Transplant Proc; 2022; 54(6):1643-1647. PubMed ID: 35810018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB
    Semin Liver Dis; 2004 May; 24(2):201-7. PubMed ID: 15192792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
    Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
    Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
    Hong JC; Jones CM; Duffy JP; Petrowsky H; Farmer DG; French S; Finn R; Durazo FA; Saab S; Tong MJ; Hiatt JR; Busuttil RW
    Arch Surg; 2011 Jun; 146(6):683-9. PubMed ID: 21690444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of an Advanced Intrahepatic Cholangiocarcinoma Effectively Treated by Conversion Surgery after Neoadjuvant Chemotherapy of Gemcitabine, Cisplatin and S-1].
    Ogura N; Hoshino M; Hayashi T; Odaira M; Harada H; Hirose S; Funakoshi S
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1665-1667. PubMed ID: 36733169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free survival.
    Gringeri E; Bassi D; D'Amico FE; Boetto R; Polacco M; Lodo E; D'Amico F; Vitale A; Boccagni P; Zanus G; Cillo U
    Transplant Proc; 2011 May; 43(4):1187-9. PubMed ID: 21620084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of liver transplantation in the treatment of cholangiocarcinoma.
    Singal A; Welling TH; Marrero JA
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation for hilar cholangiocarcinoma.
    Thelen A; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2007; 14(5):469-75. PubMed ID: 17909715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.
    Sutton TL; Billingsley KG; Walker BS; Enestvedt CK; Dewey EN; Orloff SL; Mayo SC
    Am J Surg; 2021 Jun; 221(6):1182-1187. PubMed ID: 33707077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma: A Retrospective Cohort Study.
    Nooijen LE; Franken LC; Belkouz A; Oulad Abdennabi I; Besselink MG; Busch OR; Swijnenburg RJ; Klümpen HJ; Erdmann JI
    Am J Clin Oncol; 2021 Oct; 44(10):526-532. PubMed ID: 34469345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.